Dr Eliana Barrenho is a Research Fellow at Imperial College Business School’s Centre for Health Economics & Policy Innovation. Her recent work examines the effect of policy interventions and networks on the diffusion of new technologies in health systems.

Why did you choose to study your programme and why specifically at Imperial College Business School?
I chose to apply to Imperial College because it seemed to offer more opportunities for interdisciplinary research than other economics/health economics groups. As it turned out, this was a major strength of the department – and of the Business School to which the department belongs – in that it encourages you to interact with researchers from a range of departments, especially Medicine. Throughout my PhD, I was involved in a range of seminars, talks and workshops from across management, innovation, economics & health economics, public health and surgery. All my supervision meetings were attended by both my supervisors. These meetings were incredibly helpful to me, and usually a lot of fun and good academic discussion.

What advice would you give to a prospective student considering studying a PhD?
Imperial is a fantastic place to pursue postgraduate studies in health economics. For one thing, the atmosphere is really quite hard to beat: it was a privilege to study in such a world-wide renowned university, surrounded by stunning and culturally rich museums and parks. These perks aside, the postgraduates and faculty are skilled and diverse in their research interests and enthusiastic in their support and organisation of research events based around the work of postgraduates, staff as well as top-level visiting speakers. Imperial’s health economics group is rising quickly in its international reputation, and the quality of the staff and postgraduates recruited continues to rise accordingly. It was a very intellectually productive and exciting time for me at Imperial, and I expect that Imperial’s already stellar group in health economics will continue become even better in coming years.

How did you find living in London?
Living in London has been such a great feeling – being surrounded by incredible academic community, exceptionally outstanding cultural life and such great melting-pot of ethnicities and life backgrounds.

What was the Business School community like?
The atmosphere at Imperial is very supportive and collegial; it is a healthy place to learn and work. There is also quite an exciting amount of interesting research being done in many schools and departments, so there are marvellous opportunities for interdisciplinary projects. Studying at Imperial Business School opened up doors to explore all of those issues and speak directly with leaders in their fields, companies, scientists and policy makers. And also those who are challenging it. But it wasn’t just the high profile professors – it was the calibre and thoughtfulness of my own DPhil colleagues, that really kept me thinking and exploring.

What do you enjoy most about your work and what are the main challenges that you face?
I am really passionate about health economics and I have enjoyed the work at Imperial because I had the opportunity to learn how health systems are organised. I was particularly interested in the role of incentives for innovation and how the decisions of pharmaceutical companies are addressing (or not) global health needs.

In what way is remaining connected to your alumni network important to you?
Being connected to my alumni network has given me the opportunity to stay in touch with such a rich and enthusiastic community. I hope to keep doing it for many years.

Doctoral 2014
Undergraduate degree/s :

Master of Science in Health Economics, University of York, and First Degree (Licenciatura) in Economics, Universidade Nova de Lisboa Portugal.

Employment prior to studying at the Business School :

Country Economist for Mozambique, International Growth Centre, London School of Economics and Political Science.

Employment after studying at the Business School and what is your current position :

Post-Doctoral Fellow at Paris School of Economics, and currently Research Fellow in Health Economics at Imperial College Business School.